R64K (p.Arg64Lys) variant of BCL10 (B-cell lymphoma/leukemia 10)

R64K (p.Arg64Lys) in BCL10 (B-cell lymphoma/leukemia 10) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes population frequency data and published literature.

R64K (p.Arg64Lys) variant details